These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5873402)

  • 1. [Current trends in scientific research in the pharmaceutical industry of the USA].
    Voevodin EN
    Med Prom SSSR; 1965 Dec; 19(12):54-7. PubMed ID: 5873402
    [No Abstract]   [Full Text] [Related]  

  • 2. Is pharmaceutical innovation declining?: interpreting measures of pharmaceutical innovation and regulatory impact in the USA, 1950-1980.
    Wardell WM; Sheck LE
    Ration Drug Ther; 1983 Jan; 17(1):1-7. PubMed ID: 6340163
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical companies liable for fraudulent research by subcontractors.
    Nolan KJ
    Drug Discov Today; 2004 Feb; 9(4):153-4. PubMed ID: 14960392
    [No Abstract]   [Full Text] [Related]  

  • 4. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970.
    Tobbell DA
    Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The drug industry and clinical research in interwar America: three types of physician collaborator.
    Rasmussen N
    Bull Hist Med; 2005; 79(1):50-80. PubMed ID: 15764827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of regulation on pharmaceutical research expenditures: a dynamic approach.
    Wiggins SN
    Econ Inq; 1983 Jan; 21(1):115-28. PubMed ID: 10259900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating research and development: the emergence of rational drug design in the pharmaceutical industry.
    Adam M
    Stud Hist Philos Biol Biomed Sci; 2005 Sep; 36(3):513-37. PubMed ID: 16137601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent trends in laboratory automation in the pharmaceutical industry.
    Rutherford ML; Stinger T
    Curr Opin Drug Discov Devel; 2001 May; 4(3):343-6. PubMed ID: 11560069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industrial hygiene in the pharmaceutical industry.
    Guest I; Newton D
    Occup Med; 1997; 12(1):81-94. PubMed ID: 9153054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug research in Germany--problems and chances--from the viewpoint of the drug industry].
    Weihrauch TR; Baumbauer E
    Arzneimittelforschung; 1998 Nov; 48(11):1047-50. PubMed ID: 9850422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the pharmaceutical industry.
    Stave GM; Joines R
    Occup Med; 1997; 12(1):1-4. PubMed ID: 9153049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of funding and findings of pharmaceutical research at a meeting of a medical professional society.
    Finucane TE; Boult CE
    Am J Med; 2004 Dec; 117(11):842-5. PubMed ID: 15589488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scientific harassment by pharmaceutical companies: time to stop.
    Hailey D
    CMAJ; 2000 Jan; 162(2):212-3. PubMed ID: 10674057
    [No Abstract]   [Full Text] [Related]  

  • 15. Trends in antimicrobial drug development: implications for the future.
    Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
    Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmaceutical industry--to whom is it accountable?
    Summers WK; Driscoll J; Orient JM
    N Engl J Med; 2000 Nov; 343(19):1416; discussion 1417. PubMed ID: 11183883
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmaceutical industry--to whom is it accountable?
    Bohrer RA
    N Engl J Med; 2000 Nov; 343(19):1416; discussion 1417. PubMed ID: 11183880
    [No Abstract]   [Full Text] [Related]  

  • 18. Orphan drugs--a pharmaceutical industry viewpoint.
    Goldstein GS
    Prog Clin Biol Res; 1983; 127():197-205. PubMed ID: 6889400
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. A pharmaceutical industry perspective on drug labeling.
    Robinson DS
    Psychopharmacol Bull; 1994; 30(1):23-5. PubMed ID: 7972625
    [No Abstract]   [Full Text] [Related]  

  • 20. Sociology of pharmaceuticals development and regulation: a realist empirical research programme.
    Abraham J
    Sociol Health Illn; 2008 Sep; 30(6):869-85. PubMed ID: 18761508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.